Cholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point ...

Intraductal neoplasms of the bile duct are macroscopically characterized by exophytic or polypoid growth patterns and have a favorable prognosis. Although some tumors with a predominantly tubular ...

肝内胆管癌(intrahepatic cholangiocarcinoma, iCCA)的预后不佳，很大原因是由于诊断不够及时造成的，因此iCCA的早期诊断和及早治疗是提高疾病治愈效果的 ...

Bile duct cancer cells and normal cells 3D photolithography image difference Bile duct cancer, a malignant tumor that occurs in the bile duct, is difficult to diagnose early because there are few ...

Cholangiocarcinoma is a relatively rare adenocarcinoma of the bile ducts that is rapidly fatal unless it can be completely resected. In most cases, the tumor is too advanced for resection by the ...

With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...

The albumin-bilirubin (ALBI) score can independently predict prognosis in post-surgical patients with distal cholangiocarcinoma (dCCA), a form of cholangiocarcinoma (CCA), according to results ...

Across the 3 cholangiocarcinoma subtypes, OS of more than 3 years was associated with lower percentages of PD-1+ cells among the CD8+ T cells than those with OS of less than 3 years.

Intrahepatic cholangiocarcinoma (IHCCA), a global health problem, is increasing in incidence and has differing etiologies worldwide. Next-generation sequencing (NGS) is rapidly being incorporated into ...

The “ubiquitous dependency” of cholangiocarcinoma on CDK4/6 activity, Kongpetch said, suggests that the that the CDK4/6-pRB pathway could be a treatable target.

Cholangiocarcinoma is a rare type of cancer, with approximately 8,000 people in the United States receiving a diagnosis each year, according to the American Cancer Society. FGFR2 fusions or ...